Selected research
Industry Research
STD Tests Industry Research Report 2026
Market perspective
The global STD Tests market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the STD Tests market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the STD Tests market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the STD Tests market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of STD Tests include Orasure, Hologic Inc., F. Hoffmann-La Roche, DiaSorin, Danaher Corporation, Cepheid Inc., Bio-Rad Laboratories, BioMerieux and Becton Dickinson and Company, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global STD Tests market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to STD Tests.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
STD Tests Market by Company
Orasure
Hologic Inc.
F. Hoffmann-La Roche
DiaSorin
Danaher Corporation
Cepheid Inc.
Bio-Rad Laboratories
BioMerieux
Becton Dickinson and Company
Alere Inc.
Affymetrix
Abbott Laboratories
STD Tests Segment by Type
HIV Testing
Hepatitis C Testing
Trichomonas’s Testing
Gonorrhoea Testing
Syphilis Testing
Chlamydia Testing
STD Tests Segment by Application
Diagnostic Centres
Hospitals
Homecare
Others
STD Tests Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global STD Tests market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of STD Tests and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of STD Tests.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of STD Tests companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- HIV Testing
- Hepatitis C Testing
- Trichomonas’s Testing
- Gonorrhoea Testing
- Syphilis Testing
- Chlamydia Testing
Applications
- Diagnostic Centres
- Hospitals
- Homecare
- Others
Companies covered
- Orasure
- Hologic Inc.
- F. Hoffmann-La Roche
- DiaSorin
- Danaher Corporation
- Cepheid Inc.
- Bio-Rad Laboratories
- BioMerieux
- Becton Dickinson and Company
- Alere Inc.
- Affymetrix
- Abbott Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 STD Tests by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 HIV Testing
- 2.2.3 Hepatitis C Testing
- 2.2.4 Trichomonas’s Testing
- 2.2.5 Gonorrhoea Testing
- 2.2.6 Syphilis Testing
- 2.2.7 Chlamydia Testing
- 2.3 STD Tests by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Diagnostic Centres
- 2.3.3 Hospitals
- 2.3.4 Homecare
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 STD Tests Breakdown Data by Type
- 3.1 Global STD Tests Historic Market Size by Type (2021-2026)
- 3.2 Global STD Tests Forecasted Market Size by Type (2027-2032)
4 STD Tests Breakdown Data by Application
- 4.1 Global STD Tests Historic Market Size by Application (2021-2026)
- 4.2 Global STD Tests Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global STD Tests Market Perspective (2021-2032)
- 5.2 Global STD Tests Growth Trends by Region
- 5.2.1 Global STD Tests Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 STD Tests Historic Market Size by Region (2021-2026)
- 5.2.3 STD Tests Forecasted Market Size by Region (2027-2032)
- 5.3 STD Tests Market Dynamics
- 5.3.1 STD Tests Industry Trends
- 5.3.2 STD Tests Market Drivers
- 5.3.3 STD Tests Market Challenges
- 5.3.4 STD Tests Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top STD Tests Players by Revenue
- 6.1.1 Global Top STD Tests Players by Revenue (2021-2026)
- 6.1.2 Global STD Tests Revenue Market Share by Players (2021-2026)
- 6.2 Global STD Tests Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of STD Tests Head Office and Area Served
- 6.4 Global STD Tests Players, Product Type & Application
- 6.5 Global STD Tests Manufacturers Established Date
- 6.6 Global STD Tests Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America STD Tests Market Size (2021-2032)
- 7.2 North America STD Tests Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America STD Tests Market Size by Country (2021-2026)
- 7.4 North America STD Tests Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe STD Tests Market Size (2021-2032)
- 8.2 Europe STD Tests Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe STD Tests Market Size by Country (2021-2026)
- 8.4 Europe STD Tests Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific STD Tests Market Size (2021-2032)
- 9.2 Asia-Pacific STD Tests Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific STD Tests Market Size by Country (2021-2026)
- 9.4 Asia-Pacific STD Tests Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America STD Tests Market Size (2021-2032)
- 10.2 South America STD Tests Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America STD Tests Market Size by Country (2021-2026)
- 10.4 South America STD Tests Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa STD Tests Market Size (2021-2032)
- 11.2 Middle East & Africa STD Tests Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa STD Tests Market Size by Country (2021-2026)
- 11.4 Middle East & Africa STD Tests Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Orasure
- 12.1.1 Orasure Company Information
- 12.1.2 Orasure Business Overview
- 12.1.3 Orasure Revenue in STD Tests Business (2021-2026)
- 12.1.4 Orasure STD Tests Product Portfolio
- 12.1.5 Orasure Recent Developments
- 12.2 Hologic Inc.
- 12.2.1 Hologic Inc. Company Information
- 12.2.2 Hologic Inc. Business Overview
- 12.2.3 Hologic Inc. Revenue in STD Tests Business (2021-2026)
- 12.2.4 Hologic Inc. STD Tests Product Portfolio
- 12.2.5 Hologic Inc. Recent Developments
- 12.3 F. Hoffmann-La Roche
- 12.3.1 F. Hoffmann-La Roche Company Information
- 12.3.2 F. Hoffmann-La Roche Business Overview
- 12.3.3 F. Hoffmann-La Roche Revenue in STD Tests Business (2021-2026)
- 12.3.4 F. Hoffmann-La Roche STD Tests Product Portfolio
- 12.3.5 F. Hoffmann-La Roche Recent Developments
- 12.4 DiaSorin
- 12.4.1 DiaSorin Company Information
- 12.4.2 DiaSorin Business Overview
- 12.4.3 DiaSorin Revenue in STD Tests Business (2021-2026)
- 12.4.4 DiaSorin STD Tests Product Portfolio
- 12.4.5 DiaSorin Recent Developments
- 12.5 Danaher Corporation
- 12.5.1 Danaher Corporation Company Information
- 12.5.2 Danaher Corporation Business Overview
- 12.5.3 Danaher Corporation Revenue in STD Tests Business (2021-2026)
- 12.5.4 Danaher Corporation STD Tests Product Portfolio
- 12.5.5 Danaher Corporation Recent Developments
- 12.6 Cepheid Inc.
- 12.6.1 Cepheid Inc. Company Information
- 12.6.2 Cepheid Inc. Business Overview
- 12.6.3 Cepheid Inc. Revenue in STD Tests Business (2021-2026)
- 12.6.4 Cepheid Inc. STD Tests Product Portfolio
- 12.6.5 Cepheid Inc. Recent Developments
- 12.7 Bio-Rad Laboratories
- 12.7.1 Bio-Rad Laboratories Company Information
- 12.7.2 Bio-Rad Laboratories Business Overview
- 12.7.3 Bio-Rad Laboratories Revenue in STD Tests Business (2021-2026)
- 12.7.4 Bio-Rad Laboratories STD Tests Product Portfolio
- 12.7.5 Bio-Rad Laboratories Recent Developments
- 12.8 BioMerieux
- 12.8.1 BioMerieux Company Information
- 12.8.2 BioMerieux Business Overview
- 12.8.3 BioMerieux Revenue in STD Tests Business (2021-2026)
- 12.8.4 BioMerieux STD Tests Product Portfolio
- 12.8.5 BioMerieux Recent Developments
- 12.9 Becton Dickinson and Company
- 12.9.1 Becton Dickinson and Company Company Information
- 12.9.2 Becton Dickinson and Company Business Overview
- 12.9.3 Becton Dickinson and Company Revenue in STD Tests Business (2021-2026)
- 12.9.4 Becton Dickinson and Company STD Tests Product Portfolio
- 12.9.5 Becton Dickinson and Company Recent Developments
- 12.10 Alere Inc.
- 12.10.1 Alere Inc. Company Information
- 12.10.2 Alere Inc. Business Overview
- 12.10.3 Alere Inc. Revenue in STD Tests Business (2021-2026)
- 12.10.4 Alere Inc. STD Tests Product Portfolio
- 12.10.5 Alere Inc. Recent Developments
- 12.11 Affymetrix
- 12.11.1 Affymetrix Company Information
- 12.11.2 Affymetrix Business Overview
- 12.11.3 Affymetrix Revenue in STD Tests Business (2021-2026)
- 12.11.4 Affymetrix STD Tests Product Portfolio
- 12.11.5 Affymetrix Recent Developments
- 12.12 Abbott Laboratories
- 12.12.1 Abbott Laboratories Company Information
- 12.12.2 Abbott Laboratories Business Overview
- 12.12.3 Abbott Laboratories Revenue in STD Tests Business (2021-2026)
- 12.12.4 Abbott Laboratories STD Tests Product Portfolio
- 12.12.5 Abbott Laboratories Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst